SCHEMBL5877825

SCHEMBL5877825

CC(C)Cc1cc(O)ccc1O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRA1 P14867 2/20 0.68
▸ GABRB2 P47870 2/20 0.68
▸ EGFR P00533 1/20 0.46
▸ TYR P14679 3/20 0.44
▸ HPGD P15428 4/20 0.41
▸ HSD17B10 Q99714 4/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ USP2 O75604 2/20 0.41
▸ HSP90AA1 P07900 2/20 0.41
▸ ALOX15 P16050 4/20 0.41
▸ ALOX12 P18054 4/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ TP53 P04637 3/20 0.41
▸ CYP3A4 P08684 3/20 0.41
▸ HIF1A Q16665 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ ESR1 P03372 2/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ RECQL P46063 2/20 0.41
▸ KMT2A Q03164 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9734205 0.84 GABRA1 (0.50) GABRA1GABRB2TYRESR1CYP1A2
SCHEMBL3816880 0.84 GABRA1 (0.59) GABRA1GABRB2MEN1ESR1KMT2A
SCHEMBL632575 0.83 HTR1A (0.54) GABRA1GABRB2CYP1A2CYP2C9CYP2C19
SCHEMBL9169831 0.83 GABRA1 (0.48) GABRA1GABRB2EGFRTYRHPGD
SCHEMBL5694325 0.83 GABRA1 (0.48) GABRA1GABRB2EGFRTYRHPGD
SCHEMBL1402200 0.83 TYR (0.58) GABRA1GABRB2TYRALOX15TP53
Bromide SCHEMBL11674306 0.82 TAAR1 (0.55) GABRA1GABRB2CYP1A2CYP2C9CYP2C19
SCHEMBL15255038 0.82 GABRA1 (0.47) GABRA1GABRB2EGFRTYRHPGD
SCHEMBL3960601 0.81 GABRA1 (0.66) GABRA1GABRB2HPGDHSD17B10KDM4E
SCHEMBL318750 0.81 GABRA1 (1.00) GABRA1GABRB2HPGDHSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8871385-B2 Electrodes including a polyphosphazene cyclomatrix, methods of forming the electrodes, and related electrochemical cells BATTELLE ENERGY ALLIANCE, LLC (US) 2014-10-28 — — US claimed
US-20130196223-A1 ELECTRODES INCLUDING A POLYPHOSPHAZENE CYCLOMATRIX, METHODS OF FORMING THE ELECTRODES, AND RELATED ELECTROCHEMICAL CELLS BATTELLE ENERGY ALLIANCE, LLC (US) 2013-08-01 — — US claimed
WO-2013112454-A2 ELECTRODES INCLUDING A POLYPHOSPHAZENE CYCLOMATRIX, METHODS OF FORMING THE ELECTRODES, AND RELATED ELECTROCHEMICAL CELLS BATTELLE ENERGY ALLIANCE, LLC (US) 2013-08-01 — — WO claimed
US-6403755-B1 POLYESTER COMPRISING PHOSPHAZENE MOLECULES, AROMATIC MOLECULES ATTACHED TO PHOSPHAZENE MOLECULES, AND ESTERS LINKING ADJACENT AROMATIC MOLECULES TO EACH OTHER THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF ENERGY 2002-06-11 — — US claimed
US-4599397-A MELT-MOLDABLE MITSUBISHI CHEMICAL INDUSTRIES LTD. (JP) 1986-07-08 — — US claimed
US-12201649-B2 Pharmaceutical composition comprising oxidizable biphenol and manganese porphyrin, and method of using the same VILLANOVA UNIVERSITY (US) 2025-01-21 — — US disclosed
US-20230382934-A1 HIGH ENTROPY OXIDES AND METHODS OF SYNTHESIS AND USE THEREOF NATIONAL SCIENCE FOUNDATION 2023-11-30 — — US disclosed
US-20230149451-A1 PHARMACEUTICAL COMPOSITION COMPRISING OXIDIZABLE BIPHENOL AND MANGANESE PORPHYRIN, AND METHOD OF USING THE SAME VILLANOVA UNIVERSITY (US) 2023-05-18 — — US disclosed
CN-109768320-B All-solid-state polymer electrolyte, preparation method thereof and all-solid-state lithium ion battery 南方科技大学 2021-05-07 — — CN disclosed
EP-3155051-A1 2K THERMOSETTING POWDER COATING COMPOSITIONS DSM IP Assets B.V. (NL) 2017-04-19 — — EP disclosed
WO-2015158587-A1 2K THERMOSETTING POWDER COATING COMPOSITIONS DSM IP ASSETS B.V. (NL) 2015-10-22 — — WO disclosed
EP-2802867-A1 STABILISING AND ANALYSING FATTY ACIDS IN A BIOLOGICAL SAMPLE STORED ON SOLID MEDIA Adelaide Research & Innovation Pty Ltd. (AU) 2014-11-19 — — EP disclosed
US-20020032279-A1 Flame retardant resin and flame retardant composition containing the same CHANG CHUN PLASTICS CO., LTD. 2002-03-14 — — US disclosed
EP-0934062-A4 ANTIOXIDANT ACTIVITY OF 3-DEHYDROSHIKIMATES UNIV MICHIGAN STATE (US) 2000-06-07 — — EP disclosed
EP-0934062-A1 ANTIOXIDANT ACTIVITY OF 3-DEHYDROSHIKIMATES MICHIGAN STATE UNIVERSITY (US) 1999-08-11 — — EP disclosed
WO-1998003169-A1 ANTIOXIDANT ACTIVITY OF 3-DEHYDROSHIKIMATES MICHIGAN STATE UNIVERSITY (US) 1998-01-29 — — WO disclosed
US-4835323-A Hydroquinones CIBA-GEIGY AG (CH) 1989-05-30 — — US disclosed
US-4599397-A MELT-MOLDABLE MITSUBISHI CHEMICAL INDUSTRIES LTD. (JP) 1986-07-08 — — US disclosed
US-4484000-A PHOTOGRAPHIC STABILIZERS CIBA-GEIGY AG (CH) 1984-11-20 — — US disclosed
EP-0069068-A1 Hydroquinones and their preparation CIBA-GEIGY AG (CH) 1983-01-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382934-A1 HIGH ENTROPY OXIDES AND METHODS OF SYNTHESIS AND USE THEREOF PYM1, MKI67, LGALS1 GABRA1 3560/4885GABRB2 4489/4885EGFR 511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback